In recent years, the possibility of using serum BDNF concentrations and/or studying BDNF gene polymorphisms as indicators of neuroplasticity and as potential peripheral biomarkers of depression and patients’ response to antidepressant therapy has been widely explored [24,25]. This evidence concerns the gene BDNF and depressive symptom measurement.